Indications and uses
treats head lice
treats head lice
Inspect • all household members should be checked by another person for lice and/or nits (eggs) • use a magnifying glass in bright light to help you see the lice and nits (eggs) • use a tool, such as a comb or two unsharpened pencils to lift and part the hair • look for tiny nits near the scalp, beginning at the back of the neck and behind the ears • small sections of hair (1-2 inches wide) should be examined at a...
• read all the directions and warnings in the Consumer Information Insert before use. Keep the carton. It contains important information. • store at 20 to 25°C (68 to 77°F)
Permethrin 280 mg (1%)
Lice treatment
treats head lice
For external use only
See your doctor.
ask a health professional before use.
If swallowed, get medical help or contact a Poison Control Center right away. (1-800-222-1222)
Inspect
Treat
Remove Lice/Nits
abies balsamea (balsam canada) extract, anhydrous citric acid, butylparaben, ceteth-10, cetyl alcohol, ethylparaben, FD&C yellow no. 6, fragrance, hydrolyzed animal protein, hydroxyethyl cellulose, isopropyl alcohol, methylparaben, phenoxyethanol, propylene glycol, propylparaben, purified water, stearalkonium chloride
1-888-423-0139
Permethrin Lotion, 1%
Lice Treatment Creme Rinse
THE FACTS OF LICE
Please read all information before using Lice Treatment Creme Rinse.
If you or a member of your household has head lice, don’t panic. Keep calm.
Anyone can get head lice - it has nothing to do with cleanliness or poor hygiene. Head lice are treatable and very rarely cause serious health problems.
What are head lice?
What are nits?
Because nits (eggs) hatch in about one week, all nits must be removed to stop lice.
How do head lice spread?
How do you know if you have lice?
How do you prevent the spread of lice?
How to use the creme rinse
I. Inspect
If you suspect head lice - check. Head lice may be hard to locate because they avoid light. Nits are easier to see.


II. Treat

III. Remove Lice/Nits
Treatment kills lice but does not remove the nits.

IV. Clean home and personal items
After using the creme rinse, it is very important to clean personal items and your home to prevent the spread of lice. Nits may live away from the human head for about 7-12 days. Lice may live away from the human head for about 1 day.

Warnings
For external use only
Do not use
Ask a doctor before use if you are
When using this product
Stop use and see a doctor if
If pregnant or breast-feeding,
ask a health professional before use.
Keep out of reach of children.
If swallowed, get medical help or contact a Poison Control Center right away. (1-800-222-1222)
1-800-719-9260
Distributed By
Perrigo®
Allegan, MI 49010
:95500 00 J2
CREME RINSE
PERMETHRIN LOTION 1%
Lice Treatment
SAFE
Approved for use on children over 2 months of age
With a single application
Kills lice & their eggs
Prevents reinfestation for 14 days
QUALITY GUARANTEED
COMPARE TO NIX® CREME RINSE
active ingredient
2 NIT REMOVAL COMBS AND 2 BOTTLES CREME RINSE
2 BOTTLES – 2 FL OZ (59 mL) EACH
FAMILY PACK


| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 36800-955-26 | ML - Milliliter | 36800-955 | db6a4054-312a-4048-9eae-f786aa774649 | 1 | 2018-02-20 |
| Ingredient | Type | UNII | SPL version | Uploaded |
|---|---|---|---|---|
| PERMETHRIN | ACTIVE INGREDIENT | 509F88P9SZ | 1 | |
| PERMETHRIN | ACTIVE MOIETY | 509F88P9SZ | 1 | |
| ANHYDROUS CITRIC ACID | INACTIVE INGREDIENT | XF417D3PSL | 1 | |
| BALSAM FIR LEAFY TWIG | INACTIVE INGREDIENT | H1TFV1454Z | 1 | |
| BUTYLPARABEN | INACTIVE INGREDIENT | 3QPI1U3FV8 | 1 | |
| CETETH-10 | INACTIVE INGREDIENT | LF9X1PN3XJ | 1 | |
| CETYL ALCOHOL | INACTIVE INGREDIENT | 936JST6JCN | 1 | |
| ETHYLPARABEN | INACTIVE INGREDIENT | 14255EXE39 | 1 | |
| FD&C YELLOW NO. 6 | INACTIVE INGREDIENT | H77VEI93A8 | 1 | |
| ISOPROPYL ALCOHOL | INACTIVE INGREDIENT | ND2M416302 | 1 | |
| METHYLPARABEN | INACTIVE INGREDIENT | A2I8C7HI9T | 1 | |
| PHENOXYETHANOL | INACTIVE INGREDIENT | HIE492ZZ3T | 1 | |
| PROPYLENE GLYCOL | INACTIVE INGREDIENT | 6DC9Q167V3 | 1 | |
| PROPYLPARABEN | INACTIVE INGREDIENT | Z8IX2SC1OH | 1 | |
| STEARALKONIUM CHLORIDE | INACTIVE INGREDIENT | 0OUO26BB88 | 1 | |
| WATER | INACTIVE INGREDIENT | 059QF0KO0R | 1 |
Every source-derived product name is available through these pages.
| Product NDC | Package NDC |
|---|---|
| 36800-955 | 36800-955-26 |
Every source-derived ingredient row is available through these pages.
| Name | UNII | Kind |
|---|---|---|
| PERMETHRIN | 509F88P9SZ | ACTIB |
| BALSAM FIR LEAFY TWIG | H1TFV1454Z | IACT |
| ANHYDROUS CITRIC ACID | XF417D3PSL | IACT |
| BUTYLPARABEN | 3QPI1U3FV8 | IACT |
| CETETH-10 | LF9X1PN3XJ | IACT |
| CETYL ALCOHOL | 936JST6JCN | IACT |
| ETHYLPARABEN | 14255EXE39 | IACT |
| FD&C YELLOW NO. 6 | H77VEI93A8 | IACT |
| ISOPROPYL ALCOHOL | ND2M416302 | IACT |
| METHYLPARABEN | A2I8C7HI9T | IACT |
| PHENOXYETHANOL | HIE492ZZ3T | IACT |
| PROPYLENE GLYCOL | 6DC9Q167V3 | IACT |
| PROPYLPARABEN | Z8IX2SC1OH | IACT |
| WATER | 059QF0KO0R | IACT |
| STEARALKONIUM CHLORIDE | 0OUO26BB88 | IACT |
Inactive Ingredient Database values describe FDA-listed use contexts. The match method and ambiguity count are shown because ingredient names, routes, and dosage forms are not always unique. Browse recovered IID releases and source provenance.
| DailyMed ingredient | IID ingredient | UNII | Dosage form / route | Potency | Maximum daily exposure | Match |
|---|---|---|---|---|---|---|
| METHYLPARABEN | METHYLPARABEN | A2I8C7HI9T | DROPS / ORAL | 1 mg/1ml | ||
| ANHYDROUS CITRIC ACID | ANHYDROUS CITRIC ACID | XF417D3PSL | TABLET, CHEWABLE, EXTENDED RELEASE / ORAL | 12 mg | ||
| PROPYLENE GLYCOL | PROPYLENE GLYCOL | 6DC9Q167V3 | SOLUTION / DENTAL | 2 %w/w | ||
| CETYL ALCOHOL | CETYL ALCOHOL | 936JST6JCN | SUSPENSION / AURICULAR (OTIC) | 1 %w/v | ||
| PROPYLPARABEN | PROPYLPARABEN | Z8IX2SC1OH | CAPSULE / ORAL | 1 mg | ||
| FD&C YELLOW NO. 6 | FD&C YELLOW NO. 6 | H77VEI93A8 | LIQUID / ORAL | 0.2 mg/1ml | ||
| ANHYDROUS CITRIC ACID | ANHYDROUS CITRIC ACID | XF417D3PSL | SPRAY / TOPICAL | 0.01 %w/w | ||
| FD&C YELLOW NO. 6 | FD&C YELLOW NO. 6 | H77VEI93A8 | TABLET, ORALLY DISINTEGRATING / ORAL | 12 mg | ||
| BUTYLPARABEN | BUTYLPARABEN | 3QPI1U3FV8 | LIQUID / TOPICAL | 0.02 %w/w | ||
| PROPYLENE GLYCOL | PROPYLENE GLYCOL | 6DC9Q167V3 | FILM / BUCCAL | 1.48 mg | ||
| PROPYLPARABEN | PROPYLPARABEN | Z8IX2SC1OH | GEL / TOPICAL | 4 mg | ||
| METHYLPARABEN | METHYLPARABEN | A2I8C7HI9T | ELIXIR / ORAL | 800 mg | ||
| METHYLPARABEN | METHYLPARABEN | A2I8C7HI9T | SYRUP / ORAL | 81 mg | ||
| METHYLPARABEN | METHYLPARABEN | A2I8C7HI9T | CREAM, AUGMENTED / TOPICAL | 2 mg | ||
| PROPYLENE GLYCOL | PROPYLENE GLYCOL | 6DC9Q167V3 | TABLET, DELAYED RELEASE / ORAL | 36 mg | ||
| METHYLPARABEN | METHYLPARABEN | A2I8C7HI9T | FILM / BUCCAL | 1 mg | ||
| PROPYLENE GLYCOL | PROPYLENE GLYCOL | 6DC9Q167V3 | CLOTH / TOPICAL | 0.03 mg/mg | ||
| PROPYLENE GLYCOL | PROPYLENE GLYCOL | 6DC9Q167V3 | SPONGE / TOPICAL | 40 %w/w | ||
| CETYL ALCOHOL | CETYL ALCOHOL | 936JST6JCN | TABLET, ORALLY DISINTEGRATING / ORAL | 9 mg | ||
| FD&C YELLOW NO. 6 | FD&C YELLOW NO. 6 | H77VEI93A8 | SPONGE / TOPICAL | 0.01 %w/w | ||
| PROPYLPARABEN | PROPYLPARABEN | Z8IX2SC1OH | DROPS / AURICULAR (OTIC) | NA | ||
| PROPYLENE GLYCOL | PROPYLENE GLYCOL | 6DC9Q167V3 | GEL / VAGINAL | 750 mg | ||
| PROPYLPARABEN | PROPYLPARABEN | Z8IX2SC1OH | FILM, SOLUBLE / BUCCAL | 1 mg | ||
| PROPYLENE GLYCOL | PROPYLENE GLYCOL | 6DC9Q167V3 | TABLET, FILM COATED / ORAL | 96 mg | ||
| ANHYDROUS CITRIC ACID | ANHYDROUS CITRIC ACID | XF417D3PSL | CAPSULE, LIQUID FILLED / ORAL | 360 mg | ||
| METHYLPARABEN | METHYLPARABEN | A2I8C7HI9T | INJECTION, POWDER, FOR SOLUTION / INTRAMUSCULAR | 3.6 mg | ||
| METHYLPARABEN | METHYLPARABEN | A2I8C7HI9T | SPRAY / TOPICAL | 0.2 %w/w | ||
| METHYLPARABEN | METHYLPARABEN | A2I8C7HI9T | INJECTION, SOLUTION / INTRAVENOUS | 45 mg | ||
| PROPYLENE GLYCOL | PROPYLENE GLYCOL | 6DC9Q167V3 | INJECTION / SUBCUTANEOUS | 1.4 %w/v | ||
| PROPYLPARABEN | PROPYLPARABEN | Z8IX2SC1OH | DROPS / OPHTHALMIC | 0.01 %w/w | ||
| PROPYLENE GLYCOL | PROPYLENE GLYCOL | 6DC9Q167V3 | AEROSOL, FOAM / VAGINAL | 6.4 %w/w | ||
| PROPYLENE GLYCOL | PROPYLENE GLYCOL | 6DC9Q167V3 | CREAM, AUGMENTED / TOPICAL | 8 %w/w | ||
| ANHYDROUS CITRIC ACID | ANHYDROUS CITRIC ACID | XF417D3PSL | SUSPENSION/ DROPS / OPHTHALMIC | 0.05 %w/v | ||
| METHYLPARABEN | METHYLPARABEN | A2I8C7HI9T | POWDER / ORAL | NA | ||
| ANHYDROUS CITRIC ACID | ANHYDROUS CITRIC ACID | XF417D3PSL | CLOTH / TOPICAL | 4.2 mg | ||
| BUTYLPARABEN | BUTYLPARABEN | 3QPI1U3FV8 | LOTION / TOPICAL | 4 mg | ||
| FD&C YELLOW NO. 6 | FD&C YELLOW NO. 6 | H77VEI93A8 | FILM / SUBLINGUAL | 0.03 mg | ||
| ANHYDROUS CITRIC ACID | ANHYDROUS CITRIC ACID | XF417D3PSL | INJECTION / INFILTRATION | 0.02 %w/v | ||
| ANHYDROUS CITRIC ACID | ANHYDROUS CITRIC ACID | XF417D3PSL | CAPSULE / ORAL | 131 mg | ||
| ANHYDROUS CITRIC ACID | ANHYDROUS CITRIC ACID | XF417D3PSL | AEROSOL / TOPICAL | 0.08 %w/w | ||
| BUTYLPARABEN | BUTYLPARABEN | 3QPI1U3FV8 | CAPSULE / ORAL | NA | ||
| METHYLPARABEN | METHYLPARABEN | A2I8C7HI9T | POWDER, FOR SUSPENSION / ORAL | 75 mg | ||
| PROPYLPARABEN | PROPYLPARABEN | Z8IX2SC1OH | SOLUTION / NASAL | 140 mg | ||
| FD&C YELLOW NO. 6 | FD&C YELLOW NO. 6 | H77VEI93A8 | SOAP / TOPICAL | 0.2 %w/w | ||
| ANHYDROUS CITRIC ACID | ANHYDROUS CITRIC ACID | XF417D3PSL | INJECTION, SOLUTION / SUBCUTANEOUS | 25 mg | ||
| PROPYLPARABEN | PROPYLPARABEN | Z8IX2SC1OH | CONCENTRATE / ORAL | 2.5 mg/5ml | ||
| CETYL ALCOHOL | CETYL ALCOHOL | 936JST6JCN | EMULSION / TOPICAL | NA | ||
| METHYLPARABEN | METHYLPARABEN | A2I8C7HI9T | CAPSULE / ORAL | 7 mg | ||
| ANHYDROUS CITRIC ACID | ANHYDROUS CITRIC ACID | XF417D3PSL | LOZENGE / TRANSMUCOSAL | 44 mg | ||
| PROPYLENE GLYCOL | PROPYLENE GLYCOL | 6DC9Q167V3 | TABLET, COATED / ORAL | 16 mg | ||
| PROPYLPARABEN | PROPYLPARABEN | Z8IX2SC1OH | INJECTION / PARENTERAL | 2 mg | ||
| METHYLPARABEN | METHYLPARABEN | A2I8C7HI9T | SUSPENSION/ DROPS / OPHTHALMIC | 0.05 %w/w | ||
| PROPYLENE GLYCOL | PROPYLENE GLYCOL | 6DC9Q167V3 | INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION / INTRAVENOUS | 63.4 %w/v | ||
| METHYLPARABEN | METHYLPARABEN | A2I8C7HI9T | INJECTION / INTRAVENOUS | 95 mg | ||
| ANHYDROUS CITRIC ACID | ANHYDROUS CITRIC ACID | XF417D3PSL | FILM, SOLUBLE / ORAL | 7 mg | ||
| ANHYDROUS CITRIC ACID | ANHYDROUS CITRIC ACID | XF417D3PSL | INJECTION, SOLUTION, CONCENTRATE / INTRAVENOUS | 81 mg | ||
| BUTYLPARABEN | BUTYLPARABEN | 3QPI1U3FV8 | TABLET, COATED / ORAL | 0.08 mg | ||
| PROPYLENE GLYCOL | PROPYLENE GLYCOL | 6DC9Q167V3 | FILM, EXTENDED RELEASE / TRANSDERMAL | 58.13 mg | ||
| ETHYLPARABEN | ETHYLPARABEN | 14255EXE39 | GRANULE, FOR SOLUTION / ORAL | 14 mg | ||
| PROPYLENE GLYCOL | PROPYLENE GLYCOL | 6DC9Q167V3 | INJECTION / INTRAMUSCULAR | 7459 mg |
All distinct exact application/product contexts derived from this label’s complete NDC list are paginated below.
| Application-product | Trade name | Ingredient | Strength | Dosage form / route | TE codes | RLD / RS | Approval date |
|---|---|---|---|---|---|---|---|
| A076090-001 | PERMETHRIN | PERMETHRIN | 1% | LOTION / TOPICAL | 2001-12-20 |
Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
| Captured | Edition | Application-product | Trade name | Strength | Dosage form / route | Product TE source text | RLD / RS | Approval date | Source SHA-256 |
|---|---|---|---|---|---|---|---|---|---|
| 2026-09-14 22:38:34 | 2026-08 | A076090-001 | PERMETHRIN | 1% | LOTION / TOPICAL | 2001-12-20 | 84e616aacf4f… | ||
| 2026-08-18 06:07:40 | 2026-07 | A076090-001 | PERMETHRIN | 1% | LOTION / TOPICAL | 2001-12-20 | caaa826d4ba7… | ||
| 2026-02-19 14:30 UTC | 2026-02 | A076090-001 | PERMETHRIN | 1% | LOTION / TOPICAL | 2001-12-20 | 011fe1cb6892… | ||
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A076090-001 | PERMETHRIN | 1% | LOTION / TOPICAL | 2001-12-20 | 31067a03dcf5… | ||
| 2025-08-23 18:47 UTC | 2025-08 | A076090-001 | PERMETHRIN | 1% | LOTION / TOPICAL | 2001-12-20 | 6a471c1ec25d… | ||
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | A076090-001 | PERMETHRIN | 1% | LOTION / TOPICAL | 2001-12-20 | fd3edfee7708… | ||
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | A076090-001 | PERMETHRIN | 1% | LOTION / TOPICAL | 2001-12-20 | b8a1b40f171c… | ||
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | A076090-001 | PERMETHRIN | 1% | LOTION / TOPICAL | 2001-12-20 | 03ed91905a0d… | ||
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | A076090-001 | PERMETHRIN | 1% | LOTION / TOPICAL | 2001-12-20 | 2680178bc6a6… | ||
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | A076090-001 | PERMETHRIN | 1% | LOTION / TOPICAL | 2001-12-20 | 5bbf6a4d5a75… | ||
| 2024-11-08 22:44 UTC · 3 captures of this ZIP | 2024-11 | A076090-001 | PERMETHRIN | 1% | LOTION / TOPICAL | 2001-12-20 | d8e5a09893c0… | ||
| 2024-10-29 15:01 UTC | 2024-10 | A076090-001 | PERMETHRIN | 1% | LOTION / TOPICAL | 2001-12-20 | d06236e962d9… | ||
| 2024-08-13 05:28 UTC · 3 captures of this ZIP | 2024-08 | A076090-001 | PERMETHRIN | 1% | LOTION / TOPICAL | 2001-12-20 | 79d66fd596c7… | ||
| 2024-07-13 05:37 UTC · 2 captures of this ZIP | 2024-07 | A076090-001 | PERMETHRIN | 1% | LOTION / TOPICAL | 2001-12-20 | 301d65b070ca… | ||
| 2024-06-18 03:08 UTC · 5 captures of this ZIP | 2024-06 | A076090-001 | PERMETHRIN | 1% | LOTION / TOPICAL | 2001-12-20 | 1e350fbaab3a… | ||
| 2024-05-31 18:47 UTC | 2024-05 | A076090-001 | PERMETHRIN | 1% | LOTION / TOPICAL | 2001-12-20 | 8072bd15b7f6… | ||
| 2022-06-29 02:47 UTC · 2 captures of this ZIP | 2022-06 | A076090-001 | PERMETHRIN | 1% | LOTION / TOPICAL | 2001-12-20 | 5c6f7cd8ea54… | ||
| 2022-04-08 23:34 UTC | 2022-04 | A076090-001 | PERMETHRIN | 1% | LOTION / TOPICAL | 2001-12-20 | 5d02ea3f76ae… | ||
| 2022-04-04 05:41 UTC | 2022-04 | A076090-001 | PERMETHRIN | 1% | LOTION / TOPICAL | 2001-12-20 | 4b0b4de00fa7… | ||
| 2019-12-13 00:20 UTC | 2019-12 | A076090-001 | PERMETHRIN | 1% | LOTION / TOPICAL | 2001-12-20 | 74a2ff9319b5… | ||
| 2022-03-09 01:35 UTC | 2022-03 | A076090-001 | PERMETHRIN | 1% | LOTION / TOPICAL | 2001-12-20 | bb7c543d1eb4… | ||
| 2021-12-28 21:50 UTC | 2021-12 | A076090-001 | PERMETHRIN | 1% | LOTION / TOPICAL | 2001-12-20 | 782e0a99824c… | ||
| 2021-05-05 16:15 UTC · 3 captures of this ZIP | 2021-05 | A076090-001 | PERMETHRIN | 1% | LOTION / TOPICAL | 2001-12-20 | 87673890dc5c… | ||
| 2021-03-12 10:30 UTC | 2021-03 | A076090-001 | PERMETHRIN | 1% | LOTION / TOPICAL | 2001-12-20 | 5aa47cf7b7d7… | ||
| 2020-12-22 03:56 UTC | 2020-12 | A076090-001 | PERMETHRIN | 1% | LOTION / TOPICAL | 2001-12-20 | 8869cabd3fbd… | ||
| 2020-11-12 02:37 UTC | 2020-11 | A076090-001 | PERMETHRIN | 1% | LOTION / TOPICAL | 2001-12-20 | c0c555d07b60… | ||
| 2019-12-14 00:12 UTC | 2019-12 | A076090-001 | PERMETHRIN | 1% | LOTION / TOPICAL | 2001-12-20 | 3f01610625f2… | ||
| 2019-09-15 20:21 UTC | 2019-09 | A076090-001 | PERMETHRIN | 1% | LOTION / TOPICAL | 2001-12-20 | b00525d2431f… | ||
| 2019-07-19 19:46 UTC | 2019-07 | A076090-001 | PERMETHRIN | 1% | LOTION / TOPICAL | 2001-12-20 | ea99ee380514… | ||
| 2024-03-16 18:09 UTC · 4 captures of this ZIP | 2024-03 | A076090-001 | PERMETHRIN | 1% | LOTION / TOPICAL | 2001-12-20 | 6a51e52b5d6a… | ||
| 2024-02-18 07:12 UTC | 2024-02 | A076090-001 | PERMETHRIN | 1% | LOTION / TOPICAL | 2001-12-20 | 1c564ffb4f44… | ||
| 2023-12-20 04:57 UTC | 2023-12 | A076090-001 | PERMETHRIN | 1% | LOTION / TOPICAL | 2001-12-20 | ea1830bbd6c7… | ||
| 2023-11-28 05:40 UTC · 2 captures of this ZIP | 2023-11 | A076090-001 | PERMETHRIN | 1% | LOTION / TOPICAL | 2001-12-20 | a72a2bbeb626… | ||
| 2023-10-25 00:34 UTC · 2 captures of this ZIP | 2023-10 | A076090-001 | PERMETHRIN | 1% | LOTION / TOPICAL | 2001-12-20 | 9b2671bbb829… | ||
| 2023-07-15 15:27 UTC · 2 captures of this ZIP | 2023-07 | A076090-001 | PERMETHRIN | 1% | LOTION / TOPICAL | 2001-12-20 | a67488948f0b… | ||
| 2023-06-13 01:57 UTC · 3 captures of this ZIP | 2023-06 | A076090-001 | PERMETHRIN | 1% | LOTION / TOPICAL | 2001-12-20 | 3f0d92c62455… | ||
| 2023-05-13 08:27 UTC | 2023-05 | A076090-001 | PERMETHRIN | 1% | LOTION / TOPICAL | 2001-12-20 | 053a50430f4f… | ||
| 2023-01-26 05:58 UTC | 2023-01 | A076090-001 | PERMETHRIN | 1% | LOTION / TOPICAL | 2001-12-20 | 3bdfa0b2c4d7… | ||
| 2022-11-12 20:34 UTC · 5 captures of this ZIP | 2022-11 | A076090-001 | PERMETHRIN | 1% | LOTION / TOPICAL | 2001-12-20 | 3a93d1ddd44b… | ||
| 2022-10-28 04:53 UTC | 2022-10 | A076090-001 | PERMETHRIN | 1% | LOTION / TOPICAL | 2001-12-20 | f41ea6bd6efb… |
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| 9a37792a-1ba8-4f14-8663-5b6bfaa6ab53 | 5db4d503-dcf3-4666-bc47-a319c854c42f | 2021-12-09 | Warnings | 5db4d503-dcf3-4666-bc47-a319c854c42f |
Adverse event summaries are temporarily unavailable. Other product information remains available.